In a new study, researchers identify biomarkers that may predict the efficacy of low-dose IL-2 (Ld-IL2) treatment in people with systemic lupus erythematosus (SLE). IL-2 stands for interleukin-2 – a ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen A. McMahon ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced positive data on enpatoran, an investigational, oral, novel TLR7/8 inhibitor, ...

Please provide your email address to receive an email when new articles are posted on . Patients with systemic lupus with a history of skin rashes are likely to have high interferon levels. This ...

New results from a study of a drug called Gazyva (obinutuzumab) showed that it significantly reduced disease activity in adults with systemic lupus erythematosus (SLE). The drug was developed by ...

Systemic lupus erythematosus (SLE) is a complex and potentially life-threatening autoimmune disease. Part of the complexity stems from how it can differ from person to person—giving rise to marked ...

Dear Dr. Roach: What is lupus, and what does it do to your body? I just had a friend diagnosed with it after many months of tests. — T.S.B. Dear T.S.B.: The term "lupus" generally means systemic lupus ...

The MarketWatch News Department was not involved in the creation of this content. -- Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus ...